ExodusPoint Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
ExodusPoint Capital Management's WST Position: Q3 2026 in Review
ExodusPoint Capital Management increased its West Pharmaceutical (WST) stake by 29% in Q3 2026, buying an estimated $3.13M and bringing the position to 39,734 shares worth $14.7M. The position accounts for 0.08% of the portfolio, ranked #254.
ExodusPoint Capital Management first reported a position in WST in Q2 2019 and has held it in 16 quarters since. The position peaked at $24.8M in Q3 2019. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- ExodusPoint Capital Management held 39,734 shares of West Pharmaceutical worth $14.7M as of Q3 2026.
- ExodusPoint Capital Management bought 8,874 West Pharmaceutical shares in Q3 2026, an estimated $3.13M.
- West Pharmaceutical made up 0.08% of ExodusPoint Capital Management's portfolio in Q3 2026, its #254 holding.
- ExodusPoint Capital Management first reported a position in West Pharmaceutical in Q2 2019 and has held it in 16 quarters since.
- ExodusPoint Capital Management's West Pharmaceutical position peaked at $24.8M in Q3 2019.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.